Adverum biotechnologies to participate in the cowen 45th annual health care conference

Redwood city, calif., feb. 25, 2025 (globe newswire) -- adverum biotechnologies, inc. (nasdaq: advm), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will present at the cowen 45th annual healthcare life sciences conference on tuesday, march 4 at 11:50 a.m. et.
COWN Ratings Summary
COWN Quant Ranking